Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
14 September 2022 - P1-19
Correlation between microbiome diversity, hospitalization and presence of leukocyte in sputum from Cystic Fibrosis patients based on amplicon sequence variants analysis
Andreza Martins, Fabiana Volpato, Otávio Lovison, Daiana Lima-Morales, Paulo Maróstica, Afonso Barth
14 September 2022 - P2-19
Transmission dynamics of VIM-1-producing Enterobacter cloacae complex in a tertiary care centre in Germany
Andreas Wendel, M. Thieme, F. Mattner
23 April 2022 - B0009
AZD7442 (Tixagevimab/Cilgavimab) for post-exposure prophylaxis of symptomatic COVID-19: a primary analysis and extended six-month follow-up from the STORM CHASER trial
Myron J Levin, Andrew Ustianowski, Steven Thomas, Alison Templeton, Yuan Yuan, Seth Seegobin, Catherine F Houlihan, Ibrahim Menendez-Perez, Simon Pollett, Rosalinda H Arends, Rohini Beavon, Kanika Dey, Pedro Garbes, Elizabeth J Kelly, Gavin Koh, Stefan Ivanov, Karen A Near, Audrey Sharbaugh, Katie Streicher, Menelas N Pangalos, Mark T Esser
23 April 2022 - B0006
Camostat mesylate versus lopinavir/ritonavir in hospitalised patients with COVID-19: results from a randomised, controlled, open-label, platform trial (ACOVACT)
Mario Karolyi, Erich Pawelka, Sara Omid, Franz Koenig, Victoria Kauer, Benedikt Rumpf, Wolfgang Hoepler, Avelino Kuran, Hermann Laferl, Tamara Seitz, Marianna Traugott, Vincent Rathkolb, Martin Mueller, Agnes Abrahamowicz, Christian Schoergenhofer, Manfred Hecking, Alice Assinger, Christoph Wenisch, Markus Zeitlinger, Bernd Jilma, Alexander Zoufaly
23 April 2022 - B0014
Cost-effectiveness analysis of molnupiravir versus best supportive care for the outpatient treatment of adults with COVID-19
Hardik Goswami, Adnan Alsumali, Yiling Jiang, Elizabeth R. Duke, Peter Neumann, Joshua Cohen, Amy Puenpatom
23 April 2022 - B0007
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
David Lowe, Li-An Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, Amalia Ndoutoumou, Divya Shah, Alexander Lennon, Abhulya Rai, Akosua Agyeman, Anna Checkley, Nicola Longley, Hakim-Moulay Dehbi, Nick Freemantle, Judith Breuer, Joseph Standing
23 April 2022 - B0013
Interim results from the randomised, controlled EMPATHY phase II/III study evaluating ensovibep, a DARPin therapeutic, in patients with mild-to-moderate COVID-19
Nagalingeswaran Kumarasamy, Luis Abrishamian, Marc Bonten, Richa Chandra, Pierre Fustier, Susana Goncalves, Georg Hofstetter, Awawu Igbinadolor, Jeff Kingsley, Charles G. Knutson, Philippe Legenne, Martha Mekebeb-Reuter, Krishnan Ramanathan, Shantha Rao, Evgeniya Reshetnyak, Jennifer Rosa, Marianne Soergel, Vaia Stavropoulou, Nina Stojcheva, Michael T. Stumpp
23 April 2022 - B0010
Patient-reported outcomes from COMET-ICE, a phase III study of sotrovimab for early treatment of non-hospitalised patients with COVID-19
Sacha Satram, Parima Ghafoori, Carolina M Reyes, Melissa Aldinger, Elizabeth Alexander, Helen J Birch, Dimitra Brintziki, Anil Gupta, Tom J H Keeley, Amanda Lopuski, John H Powers Iii, Elias H Sarkis, Adrienne E Shapiro
23 April 2022 - B0012
Phase IIb part of S-217622, a novel 3C-like protease inhibitor as once daily oral treatment for SARS-CoV-2 infection in Japan and South Korea
Norio Ohmagari, Hiroshi Yotsuyanagi, Yohei Doi, Takuhiro Sonoyama, Takumi Imamura, Takao Sanaki, Keiko Baba, Genki Ichihashi, Takahiro Fukuhara, Yosuke Takeda, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae
23 April 2022 - B0015
Remdesivir in the treatment of children 28 days to < 18 years of age hospitalized with COVID-19 in the CARAVAN study
Amina Ahmed, Pablo Rojo, Allison Agwu, David Kimberlin, Jaime Deville, Ana Mendez-Echevarria, Paul K. Sue, Luisa Galli, Rita Humeniuk, Kavita Juneja, Henry Hulter, Charlotte Hedskog, Catherine O’Connor, Susanne Crowe, Kathryn Kersey, Anu Osinusi, William Muller, Flor M. Munoz
23 April 2022 - B0011
Results from Ph1 and Ph2a studies of S-217622 a novel 3C-like protease inhibitor as once daily oral treatment for SARS-CoV-2 infection
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Takuhiro Sonoyama, Ryosuke Shimizu, Takumi Imamura, Takao Sanaki, Keiko Baba, Genki Ichihashi, Fukuhara Takahiro, Aya Kuwata, Yosuke Takeda, Yumiko Matsuo, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae
23 April 2022 - B0008
Virologic outcomes from MOVe-OUT, a randomised, controlled phase III trial evaluating molnupiravir for treatment of COVID-19 in non-hospitalised adults
Julie Strizki, Jay A. Grobler, Matthew G. Johnson, Michelle L. Brown, Ying Zhang, Amanda Paschke, Carisa De Anda
22 September 2021 - 19
American trypamosomiasis: Chagas Disease
Míriam Álvarez-Martínez
09 July 2021 - 19
False amoxicillin/clavulanic acid susceptibility in Bacteroides fragilis using gradient strip tests
Robert Jan Rentenaar, R.J. Rentenaar (1), B. Bovo-Heijmans (1), J. Diggle (2), A. Fluit (1), M. Wootton (3)
07 September 2018 - 19
Effect of amoxicillin metabolites on the induction of resistance to amoxicillin susceptible bacterial strains.
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.